Management ChangeJul 15, 2026, 04:16 PM

RxSight Appoints Aziz Mottiwala as New CEO

AI Summary

RxSight, Inc. announced a leadership transition effective July 20, 2026, with Aziz Mottiwala appointed as the new President and Chief Executive Officer. He succeeds Ron Kurtz, M.D., who will transition to Chief Medical Officer. Mr. Mottiwala brings significant commercial leadership experience in eye care, previously serving as Chief Commercial Officer at Tarsus Pharmaceuticals and Opiant Pharmaceuticals. Dr. Kurtz will also resign from the Board of Directors, with Mr. Mottiwala taking his place. The company stated it is not updating its financial guidance in connection with this announcement.

Key Highlights

Aziz Mottiwala appointed President and Chief Executive Officer, effective July 20, 2026.
Ron Kurtz, M.D., will transition from CEO to Chief Medical Officer.
Mr. Mottiwala brings extensive commercial leadership experience in eye care.
Dr. Kurtz will resign from the Board of Directors.
Mr. Mottiwala will be appointed to the Board of Directors.
RxSight is not updating its previously communicated financial guidance.

View SEC Filing

RXST

Ophthalmic Goods

RxSight, Inc.

Price Impact